Walder Wyss advised Axalta Coating Systems on this transaction. Axalta Coating Systems Group (NYSE: AXTA) acquired André Koch AG, an established provider of car repair and...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Boehringer Ingelheim in the transaction. Boehringer Ingelheim announced the acquisition of privately-held T3 Pharmaceuticals AG, a clinical stage Swiss biotech company, for an...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised CONVOTIS on all aspects of Swiss law on the transaction. CONVOTIS strengthens its position in Switzerland with the acquisition of acdalis AG, a...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Coopers on this transaction. Coopers Group AG, a leading Swiss personnel service provider in the field of professional and executive search, has successfully...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised the ITS shareholders in this transaction. GEODIS, one of the world’s leading transport and logistics companies, has acquired Swiss freight forwarder ITS –...
You must be a Standard 1 Year member to access this content.
Walder Wyss has advised the Avoras in this transaction. As part of its growth strategy, PwC Switzerland acquires Avoras, an established SAP-based business transformation consultant in...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Acton and VI Partners on this financing round. Specialist for electronic signatures Skribble AG, based in Zurich, has completed a round of funding...
You must be a Standard 1 Year member to access this content.
MLLStart! advised Clinical Research Ventures. Walder Wyss advises BioVersys. BioVersys AG, a privately-held clinical-stage, multi-asset Swiss pharmaceutical company focusing on research and development of therapies for...
You must be a Standard 1 Year member to access this content.
Bär & Karrer acted as legal advisor to Cawood Scientific. Walder Wyss advised IES’ shareholders in this transaction. Cawood Scientific, UK’s leading independent scientific group, announced...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised the proLogistik group on the deal. Kellerhals Carrard advised DRS Investment GmbH. The private investment company DRS Investment GmbH has sold all shares...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Dr. Wild & Co. AG in this transaction. Dr. Wild & Co. AG, the well-known Swiss family-owned company will focus on its Oral...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Dr. Wild & Co. AG in this transaction. Dr. Wild & Co. AG, the well-known Swiss family-owned company will focus on its Oral...
You must be a Standard 1 Year member to access this content.
